| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 07/19/2007 | US20070164009 Processing method and processing device |
| 07/19/2007 | CA2631360A1 Substituted bis(hetero)aromatic n-ethylpropiolamides and use thereof for production of medicaments |
| 07/18/2007 | EP1807407A1 Aromatic amides as inhibitors of c-fms kinase |
| 07/18/2007 | EP1807393A1 Diarylsulfones as 5-ht2a antagonists |
| 07/18/2007 | EP1807072A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/18/2007 | EP1636180B1 Process for rectifying n-vinyl-2-pyrrolidone |
| 07/18/2007 | EP1565436A4 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 07/18/2007 | EP1180097B1 Mutual salt of amlodipine and atorvastatin |
| 07/18/2007 | CN101001836A Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 07/17/2007 | US7244859 A chemical reaction by reacting a streptocyanine derivatives with an ester derivatives, cleavage/c-n/, formation/c-c/, desalting; UV absorbents produced by a safe, nonexplosive method |
| 07/17/2007 | US7244852 Process for preparing 2-methylpyrrolidine and specific enantiomers thereof |
| 07/17/2007 | US7244851 1-[2-Cyclohexyl-2-(2-methylamino-propionylamino)-acetyl]-pyrrolidine-2-carboxylic acid (2-phenyl-2H-pyrazol-3-yl)-amide; inhibitors of IAP, for treating malignancies |
| 07/17/2007 | US7244848 N-[4-[(1E)-3-amino-1-propenyl]phenyl]-4'-(trifluoromethyl)-[1,1'-biphenyl]-2-carboxamide; for treatment of hyperlipidemia, obesity and type II diabetes |
| 07/17/2007 | US7244758 N-type calcium channel blockers |
| 07/17/2007 | US7244753 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 07/17/2007 | US7244747 For therapy of epilepsy, epileptogenesis, seizure disorders, convulsions, dyskinesia and neuropathic pain in a mammal |
| 07/17/2007 | US7244730 Thrombin receptor antagonists; safety, specificity, oral efficacy |
| 07/17/2007 | CA2191073C Tetrahydroindeno[1,2-d][1,3,2]oxazaboroles and their use as enantioselective catalysts |
| 07/12/2007 | WO2007079078A1 Diamine derivatives as inhibitors of leukotriene a4 hydrolase |
| 07/12/2007 | WO2007079003A2 Amide inhibitors of leukotriene a4 hydrolase |
| 07/12/2007 | WO2007078990A2 Modified lysine-mimetic compounds |
| 07/12/2007 | WO2007078820A2 Methylmaleimidyl polymer derivatives |
| 07/12/2007 | WO2007053427A3 Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives |
| 07/12/2007 | WO2007048545A3 Alkoxyalkyl spirocyclic tetramic acids and tetronic acids |
| 07/12/2007 | WO2007031828A3 Therapeutic pyrrolidines |
| 07/12/2007 | WO2007029078A3 Succinimide and glutarimide derivatives as adrenergic receptor antagonists |
| 07/12/2007 | WO2006123244A3 Carbamate derivatives as positive allosteric modulators of metabotropic glutamate receptors |
| 07/12/2007 | WO2006017295A3 Tetrapeptide analogs |
| 07/12/2007 | US20070161804 Method of enantioselective nucleophilic addition reaction of enamide to imine and synthesis method of a-amino-y-keto acid ester |
| 07/12/2007 | US20070161787 (1S)-1,5-anhydro-1-[3-(1-benzothien-2-ylmethyl)phenyl-D-glucitol and derivatives are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity |
| 07/12/2007 | US20070161692 Conformationally restricted polyamine analogs as disease therapies |
| 07/12/2007 | US20070161667 Process for preparing inhibitors of nucleoside metabolism |
| 07/12/2007 | US20070161666 Pyrrolo[2,3-d]pyrimidine compounds |
| 07/12/2007 | US20070161664 Therapeutic compounds |
| 07/12/2007 | US20070161634 Compounds as CCR5 antagonists |
| 07/12/2007 | US20070161622 Diamino alcohols and their use as renin inhibitor |
| 07/12/2007 | US20070161620 Isoquinoline compound and pharmaceutical use thereof |
| 07/12/2007 | US20070161574 Hcv ns-3 serine protease inhibitors |
| 07/12/2007 | DE60125335T2 Azacyclische verbindungen zur verwendung in der behandlung von mit serotonin verwandten krankheiten Azacyclic compounds for use in the treatment of serotonin-related diseases |
| 07/12/2007 | CA2634743A1 Modified lysine-mimetic compounds |
| 07/11/2007 | EP1806400A2 Inactivation method |
| 07/11/2007 | EP1806339A1 Process for the preparation of 2-oxo-1-pyrrolidine derivatives |
| 07/11/2007 | EP1805165A1 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists |
| 07/11/2007 | EP1805141A1 Piperidines and related compounds for treatment of alzheimer's disease |
| 07/11/2007 | EP1639029B1 Biodegradable poly(beta-amino esters) and uses thereof |
| 07/11/2007 | EP1608646B1 Method for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2-(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate products |
| 07/11/2007 | EP1408961B1 2 pyrrolidone derivatives as prostanoid agonists |
| 07/11/2007 | CN1997651A Oxidative degradation products of atorvastatin calcium |
| 07/11/2007 | CN1997637A Novel o-aminophenol derivatives and colorants containing said compounds |
| 07/11/2007 | CN1997628A Thio-substituted biaryl-methanesulfinyl derivatives |
| 07/11/2007 | CN1325472C Phenyl-substituted cyclic enaminones |
| 07/10/2007 | US7242542 Filters of electronic displays |
| 07/10/2007 | US7241902 for treatment of hypertension, elevated triglycerides, and elevated insulin |
| 07/10/2007 | US7241897 Process for preparing cyanine dye labeling reagents |
| 07/10/2007 | US7241803 Compounds for inhibition of HIV infection by blocking HIV entry |
| 07/10/2007 | US7241795 2,5-bis ((alkyl (or aryl) imino) aminophenyl) furans, thiophenes or pyrroles; Mycobacterium tuberculosis, Trypanosoma spp., Candida albicans, Aspergillus spp., Cryptosporidium parvum, Giardia lamblia, Plasmodium spp., Pneumocystis carinii, Toxoplasma gondii, Fusarium solani, and Cryptococcus neoformans |
| 07/10/2007 | US7241778 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety |
| 07/10/2007 | US7241758 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
| 07/10/2007 | US7241757 Amidino derivatives and their use as thrombin inhibitors |
| 07/10/2007 | US7241721 carboxamide derivatives as active ingredients which have microbiocidal activity, in particular fungicidal activity |
| 07/10/2007 | CA2396814C Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical compositions containing them |
| 07/10/2007 | CA2370823C Metal catalysts and methods for making and using same |
| 07/10/2007 | CA2308850C Inhibitors of gap junction communication |
| 07/05/2007 | WO2007076158A2 Processes for preparing darifenacin hydrobromide |
| 07/05/2007 | WO2007075387A1 Compounds and methods for inhibiting the interaction of bcl proteins with binding partners |
| 07/05/2007 | WO2007074632A1 METHOD FOR PRODUCTION OF HETEROAROMATIC RING COMPOUND HAVING N-Rf GROUP |
| 07/05/2007 | WO2007074176A1 Novel pyrrole derivatives with histone deacetylase inhibitor activity |
| 07/05/2007 | WO2006108693A3 Process for preparing bicyclic compounds |
| 07/05/2007 | US20070155839 4-[(4-Hydroxyphenyl)(3,3,5,5-tetramethylcyclohexylidene) methyl]benzoic acid; selective estrogen receptor modulation; SERMS |
| 07/05/2007 | US20070155813 Such as methyl 3,5-dihydroxy-2-phenylphenylacetate; antitumor activity; leukemia, multiple myeloma, lymphoma; heat shock protein 90 (Hsp90) suppression |
| 07/05/2007 | US20070155803 Protease inhibitors |
| 07/05/2007 | US20070155792 Enzyme inhibitors as bactericides for infections and as enzyme inhibitors |
| 07/05/2007 | US20070155756 Treatment of chemokine mediated diseases |
| 07/05/2007 | US20070155745 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina |
| 07/05/2007 | US20070155725 N-(1-Aza-bicyclo[2.2.2]oct-3-yl)-5-cyano-2-(3,5-dichloro-phenoxy)-benzenesulfonamide; asthma, allergic rhinitis or lung granuloma, HIV; CC type chemokine receptor antagonist |
| 07/05/2007 | US20070155671 e.g. N-[2-chloro-4-[[[(3-hydroxyphenyl)methyl]amino]carbonyl]benzoyl]-3-(phenylmethyl)amino-L-alanine; intercellular adhesion molecules blocking agent; antiinflammatory; reperfusion injury following acute myocardial infarction |
| 07/05/2007 | US20070155670 Pyrrolidine Melanocortin-Specific Compounds |
| 07/05/2007 | US20070154937 N-sulfonyldicarboximide containing tethering compounds |
| 07/05/2007 | CA2635392A1 New pyrrolic derivatives with histone deacetylase inhibitory activity |
| 07/05/2007 | CA2633958A1 Compounds and methods for inhibiting the interaction of bcl proteins with binding partners |
| 07/05/2007 | CA2630478A1 Processes for preparing darifenacin hydrobromide |
| 07/04/2007 | EP1803720A1 Heterocyclindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 07/04/2007 | EP1803709A1 Proton pump inhibitors |
| 07/04/2007 | EP1802630A2 Trityl derivatives for enhancing mass spectrometry |
| 07/04/2007 | EP1802615A1 Phosphodiesterase 4 inhibitors |
| 07/04/2007 | EP1802595A1 Enantiopure heterocyclic compound useful for the preparation of peptides which can be potentially used as medicaments |
| 07/04/2007 | EP1802307A1 Pyrrolidine derivatives as histamine receptors ligands |
| 07/04/2007 | EP1802299A2 Ophthalmic compositions for treating ocular hypertension |
| 07/04/2007 | EP1397128B1 Kappa opoid agonist for the treatment of irritable bladder |
| 07/04/2007 | EP1286964B1 Heterocyclic inhibitors of glycogen synthase kinase gsk-3 |
| 07/04/2007 | EP1280769B1 Method for processing pyrollidone and n-vinyl pyrollidone residues |
| 07/04/2007 | CN1993363A 1,3-disubstituted heteroaryl nmda/nr2b antagonists |
| 07/04/2007 | CN1993319A Benzyloxy derivatives as MAOB inhibitors |
| 07/04/2007 | CN1990486A N-glycyl-pyrrolidine-2-nitrile and its use as DDP-IV enzyme inhibitor |
| 07/04/2007 | CN1990469A Pyrrolidines as dipeptidyl peptidase inhibitors |
| 07/04/2007 | CN1990468A Pyrrolidines as dipeptidyl peptidase inhibitors |
| 07/04/2007 | CN1990457A 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 07/04/2007 | CN1324008C Novel compounds and compositions as cathepsin inhibitors |
| 07/04/2007 | CN1324004C New phenyl-naphthalene derivatives, and preparation method and drug containing same |
| 07/03/2007 | US7238725 Tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |